Novel melanoma antigens

The invention relates to melanoma antigen named MELOE and their use for preventing, treating and diagnosing melanoma.

Keywords: Melanoma, antigen, peptide, MELOE-1, MELOE-2
Patent Application number: European Procedure (Patents) (EPA) - 02 Sept. 2008 - 08 305 517.8
Inventors:
MOREAU-AUBRY AgnèsGODET Yann
Publications:
Oncoimmunology 2019 : Cancer Vaccines: Designing Artificial Synthetic Long Peptides to Improve Presentation of Class I and Class II T Cell Epitopes by Dendritic Cells
J Exp Med. 2008
205 (11) 2673-82/t
Cancer Immunol Immunother 2011 60 (3)
327-37
Eur. J. Immunol. 2010. 40: 1786–94 /t
PLoS One. 2013; 8(9): e75421

Reference:

BIO08305-T1

Business Developper
contact
Aymeric Empereur
Business Developer
Patent filling date: 02-09-2008
Rare disease: No
Second indication: No

You might also be interested in